Introduction Cervical cancer is the leading cause of cancer deaths in women in the
developing world. New technologies have been developed to allow for more rapid, cost …

Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

Emerging evidence suggests associations between the vaginal microbiota (VMB)
composition, human papillomavirus (HPV) infection, and cervical intraepithelial neoplasia …

The vaginal microbiota plays a significant role in health and disease of the female
reproductive tract. Next-generation sequencing techniques based upon the analysis of …

An update to the American Cancer Society (ACS) guideline regarding screening for the early
detection of cervical precancerous lesions and cancer is presented. The guidelines are …

Background HPV testing is replacing cytology for cervical cancer screening because of
greater sensitivity and superior reassurance following negative tests for the dozen HPV …

Abstract Changes in cervico-vaginal microbiota with Lactobacillus depletion and increased
microbial diversity facilitate human papillomavirus (HPV) infection and might be involved in …

Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …

Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any
given point in time is approximately 10% indicating that HPV is one of the most common …

Background The natural history of human papillomavirus (HPV) infections in older women is
critical for preventive strategies, including vaccination and screening intervals, but is poorly …